118th Congress · SENATE BILLBILL

S. 125 — China Trade Relations Act of 2023

“A bill to withdraw normal trade relations treatment from, and apply certain provisions of title IV of the Trade Act of 1974 to, products of the People's Republic of China, and to expand the eligibility requirements for products of the People's Republic of China to receive normal trade relations treatment in the future, and for other purposes.”

Foreign trade and international finance

Introduced Jan 26, 2023

Last action Jan 26, 2023

Pipeline · Bill → Law

Step 1

Introduced

Jan 26, 2023

Step 2

Referred

Jan 26, 2023

Finance

Step 3

Committee

Step 4

Senate

Step 5

House floor

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill withdraws normal trade relations treatment from China and expands the bases of ineligibility for this treatment to include specified violations of human rights by China. Specifically, during any period in which China engages in specified activities (e.g., using slave labor, performing forced abortion or sterilization, or hindering the free exercise of religion) (1) products from China shall not be eligible to receive nondiscriminatory treatment (normal trade relations), (2) China may not participate in any U.S. program that extends credits or credit guarantees or investment guarantees, and (3) the President may not conclude any commercial agreement with China.

Provisions · 3 sectionsIntroduced in Senate

Timeline · 2 actions

Jan 26, 2023

Introduced in Senate

Jan 26, 2023

Read twice and referred to the Committee on Finance.